IMGN News and Press, ImmunoGen Inc. From 11/01/19

ImmunoGen Inc (IMGN) Q3 2019 Results Earnings Conference Call November 1, 2019 8:00 AM ET Company Participants Courtney O'Konek - Senior Director of Corporate Communications and Investor Relations Mark Enyedy - President and Chief Executive Officer Anna Berkenblit - Senior Vice...

Image source: The Motley Fool. Immunogen Inc   (NASDAQ: IMGN) Q3 2019 Earnings Call Nov 1, 2019 , 8:00 a.m. ET Operator Continue reading

ImmunoGen ( IMGN ) Q3 results : Revenues: $13.3M (+22.0%). More news on: ImmunoGen, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...

ImmunoGen (NASDAQ: IMGN ): Q3 GAAP EPS of -$0.15 beats by $0.03 . More news on: ImmunoGen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Full Mirvetuximab Soravtansine Phase 3 FORWARD I and Initial Phase 1b FORWARD II Triplet Data Presented at ESMO Phase 3 MIRASOL Trial for Mirvetuximab in Ovarian Cancer on Track to Start by Year-End Updated IMGN632 AML and BPDCN Monotherapy Data Accepted as Oral Presentation at A...

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, November 1, 2019 to discuss its third quarter operating results. Management...

Small-cap stocks have been weighed down by ongoing uncertainty associated with trade deals and interest rate policy, making it harder than ever to spot potential winners and limit risk. Although small-cap stocks could face headwinds if the economy decelerates, there are specific industries and...

Small-cap stocks have underperformed large-cap stocks, and recent manufacturing and services industry data increases concerns that profits could stagnate. The risk of decelerating economic activity to small-cap stocks shouldn't be ignored, but that doesn't mean there aren't sectors, industries...

Introduction This forensic value analysis began with a check of four different algorithm scores of Tesla, Inc. ( TSLA ) at the request of members of my service back in October 2018. The question they asked at the time was, "what risk does Tesla, Inc. pose as an investment?" In an ad-hoc quer...

Dova Pharmaceuticals (NASDAQ: DOVA ) +39%  on being acquired by Sobi. More news on: Dova Pharmaceuticals, Inc., Bed Bath & Beyond Inc., ImmunoGen, Inc., Stocks on the move, Read more ...